SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/10/12 Hi Tech Pharmacal Co Inc 10-Q 7/31/12 64:3.3M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 319K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 24K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K 4: EX-32 Certification -- §906 - SOA'02 HTML 18K 41: R1 Document and Entity Information HTML 38K 31: R2 Condensed Consolidated Balance Sheets HTML 120K 39: R3 Condensed Consolidated Balance Sheets HTML 39K (Parenthetical) 43: R4 Condensed Consolidated Statements of Operations HTML 94K (Unaudited) 58: R5 Consolidated Statements of Comprehensive Income HTML 34K (Unaudited) 33: R6 Condensed Consolidated Statements of Cash Flows HTML 80K 38: R7 Basis of Presentation HTML 29K 28: R8 Business HTML 22K 20: R9 Revenue Recognition HTML 21K 59: R10 Net Income Per Share HTML 23K 45: R11 Accounts Receivable HTML 55K 44: R12 Inventory HTML 28K 49: R13 Property and Equipment HTML 33K 50: R14 Intangible Assets HTML 52K 48: R15 Long-Term Debt HTML 25K 51: R16 Freight Expense HTML 20K 40: R17 Stock-Based Compensation HTML 35K 42: R18 Product Divestitures HTML 22K 47: R19 Income Taxes HTML 26K 63: R20 Contingencies and Other Matters HTML 47K 54: R21 Recent Accounting Pronouncements HTML 28K 35: R22 Significant Customers and Concentration of Credit HTML 25K Risk 46: R23 Fair Value Measurements HTML 37K 37: R24 Segment Information HTML 53K 15: R25 Accounts Receivable (Tables) HTML 51K 55: R26 Inventory (Tables) HTML 26K 60: R27 Property and Equipment (Tables) HTML 31K 24: R28 Intangible Assets (Tables) HTML 42K 23: R29 Stock-Based Compensation (Tables) HTML 29K 26: R30 Fair Value Measurements (Tables) HTML 27K 27: R31 Segment Information (Tables) HTML 44K 29: R32 Net Income Per Share (Details) HTML 19K 14: R33 Accounts Receivable (Details) HTML 28K 52: R34 Accounts Receivable (Details 1) HTML 32K 34: R35 Accounts Receivable (Details Textual) HTML 21K 36: R36 Inventory (Details) HTML 29K 18: R37 Property and Equipment (Details) HTML 34K 62: R38 Property and Equipment (Details Textual) HTML 29K 11: R39 Intangible Assets (Details) HTML 47K 30: R40 Intangible Assets (Details Textual) HTML 97K 57: R41 Long-Term Debt (Details) HTML 45K 17: R42 Freight Expense (Details) HTML 19K 22: R43 Stock-Based Compensation (Details) HTML 26K 25: R44 Stock-Based Compensation (Details Textual) HTML 42K 32: R45 Product Divestitures (Details) HTML 34K 13: R46 Income Taxes (Details) HTML 25K 19: R47 Contingencies and Other Matters (Details) HTML 65K 12: R48 Significant Customers and Concentration of Credit HTML 25K Risk (Details) 56: R49 Fair Value Measurements (Details) HTML 23K 16: R50 Fair Value Measurements (Details Textual) HTML 20K 53: R51 Segment Information (Details) HTML 35K 61: XML IDEA XML File -- Filing Summary XML 91K 21: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 456K 5: EX-101.INS XBRL Instance -- hitk-20120731 XML 686K 7: EX-101.CAL XBRL Calculations -- hitk-20120731_cal XML 118K 8: EX-101.DEF XBRL Definitions -- hitk-20120731_def XML 233K 9: EX-101.LAB XBRL Labels -- hitk-20120731_lab XML 722K 10: EX-101.PRE XBRL Presentations -- hitk-20120731_pre XML 484K 6: EX-101.SCH XBRL Schema -- hitk-20120731 XSD 141K 64: ZIP XBRL Zipped Folder -- 0001193125-12-386176-xbrl Zip 82K
EX-32 |
Exhibit 32
HI-TECH PHARMACAL CO., INC.
CERTIFICATION PURSUANT TO 18 U. S. C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of Hi-Tech Pharmacal Co., Inc. (the “Company”), hereby certify to such officers’ knowledge, that the Company’s Quarterly Report on Form 10-Q for the period ended July 31, 2012 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: September 7, 2012
/s/ David S. Seltzer |
Chief Executive Officer |
/s/ William Peters |
Chief Financial Officer |
This certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 9/10/12 | None on these Dates | ||
9/7/12 | ||||
For Period end: | 7/31/12 | |||
List all Filings |